| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Harmony Biosciences Holdings, Inc
13G/A
HRMY · 413197104
|
3.2% |
11/14/2025
Event 9/30/2025
|
||||
| Valor IV Pharma Holdings, LLC | 0% | |||||
| Valor Equity Partners IV L.P. | 1.3% | |||||
| Valor Equity Partners IV-A L.P. | 0% | |||||
| Valor Equity Partners IV-B L.P. | 0.7% | |||||
| Valor Equity Associates IV L.P. | 2.2% | |||||
| Valor Equity Capital IV LLC | 2.2% | |||||
| Valor Management L.P. | 2.2% | |||||
| Antonio J. Gracias | 3.2% | |||||
| Juan A. Sabater | 2.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.